Search

1201004
1195994
393884
209802
1197163
Community Engagement
In March 2016 SATVI brought "Lienkie se Longe", a drama to raise awareness about TB, to the Worcester Easter Festival. The drama tells the story of Lienkie, whose lungs “talk with each other’ about their health and the health of Lienkie’s boyfriend...
Biomarker discovery offers hope for new TB vaccine development
A team of scientists from the University of Cape Town, Oxford University and the London School of Hygiene & Tropical Medicine have made a discovery that reveals how we can improve development of more effective vaccines against tuberculosis.
Community Engagement
In 2012 SATVI developed a drama production to promote awareness about TB vaccine clinical research, titled “Carina’s Choice” with learners from Worcester Secondary School as actors and UCT drama school students as mentors. A very successful roadshow...
Accredited UCT Research Centre
The South African Tuberculosis Vaccine Initiative (SATVI) is an accreditated Research Centre of the University of Cape Town.
Kick TB Schools Program 17- 27 May 2016
On Tuesday 17 May 2016, SATVI kicked off a districtwide TB awareness raising program, in partnership with TB Alliance, the Western Cape Education Department, AERAS, TB Care (USAID), in Robertson.

News

Monday, 23 October 2017
2 September 2017 Beadmaking to Beat TB

On Thursday 24 August 2017, the South African Tuberculosis Vaccine Initiative (SATVI) partnered with Ikamva Lethu, a women’s cooperative based in Worcester, in presenting a bead making workshop to learners at the Sinetemba Aftercare Centre in Zwelethemba, Worcester.

Publication Date:
Wednesday, September 6, 2017 - 10:15
23 August 2017 Research Published: The CSF Immune Response in HIV-1–Associated Cryptococcal Meningitis: Macrophage Activation, Correlates of Disease Severity, and Effect of Antiretroviral Therapy

SATVI researcher Associate Professor Tom Scriba has co-authored a research paper titled: "The CSF Immune Response in HIV-1–Associated Cryptococcal Meningitis: Macrophage Activation, Correlates of Disease Severity, and Effect of Antiretroviral Therapy" appearing in the Journal of Acquired Immune Deficiency Syndrome.

Publication Date:
Wednesday, August 23, 2017 - 14:30
15 August 2017 NEW VACANCY: Laboratory Technologist

South African Tuberculosis Vaccine Initiative (SATVI), located within Infectious Disease and Molecular Medicine (IDM) at the Faculty of Health Sciences invites applications from suitably qualified candidates for a 24-month contract position of Laboratory Technologist based in Worcester.                       CLOSED

Publication Date:
Tuesday, August 15, 2017 - 14:30
14 August 2017 Research: Optimization and interpretation of serial QuantiFERON testing to measure acquisition of M. tuberculosis infection

SATVI authors have published research in which they find that the implementation of optimized procedures and a more rigorous QuantiFERON-TB conversion definition, an increase from IFNy<0.2 to >0.7 IU/mL, would allow more definitive detection of recent M.tb infection and potentially improve identification of those more likely to develop disease.

Publication Date:
Tuesday, August 15, 2017 - 13:15

Pages